An observational study in Postoperative Complications, Children and Neonate, sponsored by University of Sao Paulo. Recruiting at 1 site in Brazil. Open to participants aged 1 Day to 18 Years. Per ClinicalTrials.gov, last updated 2024-12-09.
Sponsored by University of Sao Paulo · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 36 studies in Postoperative Complications with a site in Brazil — 8 open to participants now, 8 under way, none of them phase 3. Postoperative Complications · Brazil.
Among the 36 studies in Postoperative Complications with a site in Brazil, this one is the 2nd largest by planned enrollment of the 11 observational ones that give a count, is the only one that started in 2023, is one of 11 observational ones, and was the 28th registered.
1,343 studies on the registry are indexed under Postoperative Complications; 314 are open to participants now.
Browse Postoperative Complications studies →8 of the 36 studies in Postoperative Complications with a site in Brazil are open now. Recruiting first, the newest first:
Federal University of Minas Gerais · Sites in Brazil
Ages 18+
Getúlio Vargas University Hospital · Sites in Brazil
Ages 18+
Hospital de Clinicas de Porto Alegre · Sites in Brazil
Ages 18+
Hospital Nossa Senhora da Conceicao · Sites in Brazil
Ages 18+
University of Sao Paulo · Sites in Brazil
Ages 18+ · Healthy volunteers
A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →
Of the 200 Postoperative Complications studies recruiting now, 126 (63%) set no upper age limit and 31 (16%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.
This study: 1 Day to 18 Years · all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
36 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 1 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 10,000 is above the median of 251 across 541 observational studies indexed under Postoperative Complications.
Median enrollment 118 across the 25 interventional studies, 362 across the 11 observational. Of the 16 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 36 has an industry lead sponsor. The 10 most frequent:
University of Sao Paulo is the lead sponsor of 1,036 studies on the registry; 96 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
University of Sao Paulo has 7 studies filed under Postoperative Complications — fewer than ten, so there is no comparison to draw.
2 of the studies in Postoperative Complications with a site in Brazil that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07675421Federal University of Minas GeraisImpact of HMB Supplementation on Inflammation and Outcomes in Head and Neck Cancer | 2027-08-31 |
| NCT06953128Hospital de Clinicas de Porto AlegreGeneral Versus Regional Anesthesia in Peripheral Arterial Surgery | 2027-11-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 36 studies in Postoperative Complications with a site in Brazil, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective, international, multicenter observational study will include hospitals performing pediatric surgery in participating Latin American countries.
We aim to assess the incidence of hospital postoperative complications in pediatric surgical patients \< 18-years-old in Latin America. We will recruit all consecutive pediatric patients under the age of 18 years who were admitted to participating hospitals undergoing elective and nonelective surgery. The primary outcome is in-hospital postoperative complications up to 30 days after surgery.
Background
Surgery is a cost-effective public health intervention. However, there are significant disparities in access to and in the safety of surgical and anesthesia services in low- and middle-income countries compared to high-income countries. (1) Additionally, there is a significant burden of surgical disease in the pediatric surgical population with a significant unmet need. (2,3) In Africa, children represent a significant proportion of the population, with approximately 50% of the population aged \<19 years; moreover, this proportion is very similar in Latin America. (4) Postoperative complications are an important determinant of surgical morbidity and mortality. Limited data from Africa and Latin America suggest that risk factors, incidence, and outcomes associated with pediatric surgical complications differ in high-income countries. In the South African Pediatric Surgical Outcomes Study (SAPSOS), patients in this middle-income country (5) had twice the incidence of complications (6-8), and the types of complications differed from those in high-income countries, with a predominance of infectious complications. Furthermore, risk factors for complications (including ASA physical status, urgent surgery, surgery severity, and infectious indication for surgery) were different from those in high-income countries, wherein the risk factors include post-conceptual age, ASA physical status > 3, history of cardiovascular disease, and cardiovascular, neurological, or orthopedic surgical procedures. (9) Postoperative mortality was observed to be ten times higher in
South Africa than in a prospective study in high-income countries. (10) Furthermore, a prospective study of pediatric perioperative mortality in 24 Kenyan hospitals demonstrated a 7-day postoperative mortality of 1.7% (11), which is 17 times higher than that reported in high-income countries.
The African Surgical Outcomes Study (ASOS) described surgical outcomes in African adult patients. (12) Specifically, patients had a lower risk profile and fewer complications than those in high-income countries. However, postoperative mortality was twice the global average. A similar study is being performed in Latin America (LASOS), which also includes adults.
It is necessary to determine the importance of complications in pediatric surgical patients in Latin America, as well as the risk factors and types of complications that are experienced by these patients, due to the fact that data on this population are scarce. Consequently, we will be able to target appropriate interventions and funding to improve surgical outcomes for children in Latin America.
Study objectives
Primary objective
To determine the incidence of in-hospital postoperative complications up to 30 days after surgery in Latin American pediatric surgical patients (under 18-years-old).
Secondary objectives
In pediatric surgical patients under 18 years of age in Latin America, we aim to:
Methods
Study design
14-day Latin American international multicenter prospective cohort study of pediatric patients (\<18 years) undergoing surgery.
Inclusion criteria
All of the consecutive patients under 18-years-old who were admitted to participating hospitals during the study period and who underwent elective and nonelective surgeries will be included in the study. This analysis will include outpatient surgeries and surgical procedures outside of operating rooms requiring local or general anesthesia. Recruitment will occur for fourteen days, starting on the date chosen by each participating hospital within the study cohort period (to be determined).
Exclusion criteria
Hospitals
Our goal is to recruit as many Latin American hospitals as possible. Each hospital will receive an individual report that compares its dataset with that of the overall national cohort.
Ethics in research and informed consent
Research ethics and regulatory approvals will be sought before the initiation of the study in each location by using national research legislation/guidelines for that country.
National leaders will ensure that the necessary ethical and regulatory approvals are obtained for participating hospitals in their country. Hospitals can only record data if there is ethical approval or an equivalent waiver.
This study is a large-scale clinical audit; therefore, it does not pose a significant risk to the study population. In most, if not all, countries, there will be no requirement for individual patient consent, as all of the data will be anonymized and are expected to be recorded as part of routine clinical practice.
A precedent has already been set from an international perspective. In the original EuSOS study, consent was provided in 27 of the 28 participating European countries. (13) In the ASOS study (12) and the ASOS-2 trial, consent was provided in most hospitals. In African pediatric perioperative studies, written informed consent was provided by six of eight ethics committees in the SAPSOS (5) study. Additionally, in a study in Kenya, written informed consent was provided in all 24 participating hospitals. (11) The LASOS study also obtained a consent form waiver from the coordinating center (Hospital das Clínicas HCFMUSP).
Informational signage documents will be used at participating sites to ensure that all of the patients and parents/guardians know that the hospital is participating in the study. These handover documents will be placed in critical areas of the participating hospitals, with explanations of the dates and nature of the study.
Recruitment and screening
We expect that all consecutive pediatric patients under 18 years undergoing elective and nonelective surgeries will be included in the study. Each hospital must record and submit a triage record of all of the eligible patients. Publicity through the appropriate hospital notices and signage will inform patients, their parents/guardians, and the public that the hospital is participating in the study.
Data collection and grouping
Each hospital will individually collect and record data on an electronic or paper case recording form (CRF) for each recruited patient. Paper CRFs will be stored in a locked office at each hospital, as they will include patient-identifiable data to allow for the tracking of clinical outcomes.
Data will be pseudoanonymized by generating a unique numeric code and transcribed by local investigators into a secure, password-protected electronic CRF on the REDCap platform. Each patient will be solely identified on the electronic CRF by their numerical code; thus, the study coordinating team can only trace the data back to an individual patient with contact with the local team. A participant (patient) list will be used at each hospital to match the identification codes in the database to individual patients to record clinical results and to provide any missing data points. Access to the data entry system will be protected by the username and password provided during the registration process to individual local investigators. All of the electronic data transfers between participating hospitals and the coordinating center will be encrypted by using a secure protocol (HTTPS/SSL 3.0 or higher).
When individual hospitals are unable to access the registration form over the internet, pseudoanonymous coded data can also be faxed, registered mailed, emailed, or WhatsApp messaged to the coordinating center (if necessary).
Each hospital will maintain a secure trial file, including a protocol, local investigator delegation record, ethics approval documentation, participant list, and other documentation (such as trial definitions).
A printout of the final summary of the included patients with essential variables should be produced for each hospital, along with the submission of final data for double-checking for completeness and accuracy.
Sample size calculation
We plan to recruit as many hospitals from each participating country as possible and ask them to include all eligible patients in the study. We do not have a specific sample size, and statistical models will be adapted to the event rate provided by the recruited sample to avoid inappropriate use of any logistic regression models.
Statistical analysis
The data to be collected are all collected as part of routine clinical care. Categorical variables will be described as proportions and compared by using chi-square tests. Continuous variables will be described as the mean and standard deviation if normally distributed or as the median and interquartile range if not normally distributed. The univariate analysis will test factors associated with postoperative complications, intensive care admission, and in-hospital death.
Hierarchical multilevel logistic regression models will be constructed to identify factors that are independently associated with these outcomes and to adjust for differences in confounding factors. Factors will be entered into the models based on their univariate relationship with the outcome (p\<0.05), biological plausibility, and low rate of missing data. Logistic regression results will be reported as adjusted odds ratios (ORs) with 95% confidence intervals. Moreover, models will be evaluated by using sensitivity analyses to explore possible interacting factors and to examine any effect on the results. A statistical analysis plan will be written before the analysis.
Primary outcome
Postoperative complications in the hospital up to 30 days after surgery.
Secondary outcomes
Children submitted to surgery (elective and non-elective).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
We will follow children submitted to surgery until hospital discharge or until 30 days after surgery.
Procedure: Surgery
All children submitted to surgery will be followed until hospital discharge or 30 days postoperatively.
Postoperative in-hospital complication
Percentage of postoperative complications in-hospital
Time frame: until 30 days
Surgical mortality
Percentage of surgical mortality in-hospital
Time frame: until 30 days
Admission to critical care
Percentage of children admitted in critical care
Time frame: until 30 days
Plan to share: No
Started Dec 2023 (actual). Primary completion is estimated for Feb 2025, 14 months after the start.
Of 276 non-industry observational studies under Postoperative Complications, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's planned 14 months is below that.
Counting every sponsor, half of 281 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.